December 15th, 2015

Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting

[Business Wire] – Biogen Idec will present more than 60 company-sponsored platform and poster presentations on data supporting its marketed and investigational therapies for neurological diseases at the 66th American Academy of Neurology . . . → Read More: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting Similar Articles: Stock Update (NASDAQ:BIIB): Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.